Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors

Since target therapy with mTOR inhibitors plays an important role in the current management of clear cell renal cell carcinoma (RCC), there is an increasing demand for predictive biomarkers, which may help to select patients that are most likely to benefit from personalized treatment. When dealing w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Fiorini, Claudia, Massari, Francesco, Pedron, Serena, Sanavio, Sara, Ciccarese, Chiara, Porcaro, Antonio Benito, Artibani, Walter, Bertoldo, Francesco, Zampini, Claudia, Sava, Teodoro, Ficial, Miriam, Caliò, Anna, Chilosi, Marco, D’Amuri, Alessandro, Sanguedolce, Francesca, Tortora, Giampaolo, Scarpa, Aldo, Delahunt, Brett, Porta, Camillo, Martignoni, Guido, Brunelli, Matteo
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4266722/
https://ncbi.nlm.nih.gov/pubmed/25520878
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars